Study S002214

Pioneering and Affordable Strategies to Prevent Progression of Prediabetes, Obesity and CV Risk in Hispanics

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06446531
Acronym: Pre-DM
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: SINGLE
Status: RECRUITING
Enrollment: 64
Start: 2024-09-11
Primary completion: 2027-07
Lead sponsor: The University of Texas Health Science Center at San Antonio
Conditions: Pre-Diabetes; Weight, Body; Cardiovascular Diseases
Interventions: DRUG:Placebo; DRUG:Rybelsus Tablet; DRUG:Jardiance 25Mg Tablet; DRUG:Metformin; DRUG:Actos
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Hemoglobin A1c Level (HBA1c) [Baseline and 6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.